CLEARPOINT NEURO INC
CLEARPOINT NEURO INC logo
CLPT

CLEARPOINT NEURO INC (CLPT)

$9.433.63%

Market is closed
– opens on 8 PM, 01 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$8.935
Day's Range
$9.51
$7.0
52-Week Range
$16.96
1 month return4.55%
3 month return24.44%
1 year return25.51%
5 year return48.92%

Company Information

ClearPoint Neuro's mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy. Applications of the Company's current product portfolio include deep-brain stimulation, laser ablation, biopsy, neuro-aspiration, and delivery of drugs, biologics, and gene therapy to the brain. The ClearPoint Neuro Navigation System has FDA clearance, is CE-marked, and is installed in over 60 active clinical sites in the United States, Canada, and Europe. The Company's SmartFlow® cannula is being used in partnership or evaluation with 25 individual biologics and drug delivery companies in various stages from preclinical research to late-stage regulatory trials. To date, more than 4,000 cases have been performed and supported by the Company's field-based clinical specialist team which offers support and services for its partners.
OrganizationCLEARPOINT NEURO INC
Employees80
CEOMr. Joseph Michael Burnett
IndustryHealth Technology

Analyst Recommendation

based on 1 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 1 Wall street analysts offering stock ratings for CLEARPOINT NEURO INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 114.74%

Current

$9.43

Target

$20.25

Recommendation Trend

Based on 1 analyst

Current1M Ago3M Ago
Buy
1
7
7
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
223.4M
Book Value
$1.63
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-0.72
Wall Street Target Price
20.25

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
5.47
Enterprise Value
189.8M
Enterprise Value/Revenue
9.65
Enterprise Value/Ebitda
-12.6

Technicals

Beta
1.11
50 Day MA
10.05
200 Day MA
10.87

Institutional Holdings

Vanguard Group Inc

4.03%

Brown Advisory Holdings Inc

1.32%

Millennium Management LLC

0.78%

Taylor Frigon Capital Management LLC

0.73%

Geode Capital Management, LLC

0.7%

Cahill Wealth Management, LLC

0.54%

Discover more

Frequently Asked Questions

What is CLEARPOINT NEURO INC share price today?

Can Indians buy CLEARPOINT NEURO INC shares?

How can I buy CLEARPOINT NEURO INC shares from India?

Can Fractional shares of CLEARPOINT NEURO INC be purchased?

What are the documents required to start investing in CLEARPOINT NEURO INC stocks?

What are today’s High and Low prices of CLEARPOINT NEURO INC?

What are today’s traded volumes of CLEARPOINT NEURO INC?

What is today’s market capitalisation of CLEARPOINT NEURO INC?

What is the 52 Week High and Low Range of CLEARPOINT NEURO INC?

How much percentage CLEARPOINT NEURO INC is down from its 52 Week High?

How much percentage CLEARPOINT NEURO INC is up from its 52 Week low?

What are the historical returns of CLEARPOINT NEURO INC?

Who is the Chief Executive Officer (CEO) of CLEARPOINT NEURO INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*